ROBERT IRWIN: Open Payments
NPI 1801414495 · ZACHARY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,212 in 122 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $164 · 2025 $2,212
Food & beverage: $2,143Education: $69
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $478 |
| Lilly USA, LLC | 14 | $325 |
| Janssen Biotech, Inc. | 17 | $300 |
| GENZYME CORPORATION | 8 | $179 |
| PFIZER INC. | 13 | $168 |
| Arcutis Biotherapeutics, Inc. | 4 | $160 |
| Incyte Corporation | 8 | $148 |
| Galderma Laboratories, L.P. | 12 | $136 |
| Regeneron Healthcare Solutions, Inc. | 4 | $114 |
| LEO Pharma Inc. | 5 | $92 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, TALTZ, RINVOQ, Zoryve, OPZELURA, CIBINQO.
Industry payments across LA — which companies pay providers there.
